Biostate AI develops generative AI that benefit all human health.
Biostate AI has raised $12.0M in total funding. The most recent round was Series A. The last funding was announced in May 2025.
Biostate AI's investors include Accel, Gaingels, Matter Venture Partners, Mana Ventures, Info Edge ventures.
Biostate AI is headquartered in Palo Alto, United States.
Biostate AI develops generative AI that benefit all human health.
Biostate AI is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biostate AI — Funding & Investors." VCBacked, May 20, 2025, https://www.vcbacked.co/company/biostate-ai. Accessed September 10, 2026.
VCBacked. (2025). Biostate AI — Funding & Investors. Retrieved September 10, 2026, from https://www.vcbacked.co/company/biostate-ai
{{cite web |title=Biostate AI — Funding & Investors |url=https://www.vcbacked.co/company/biostate-ai |website=VCBacked |access-date=September 10, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated